News Conference News ESC 2018 FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice Todd Neale August 26, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients Michael O'Riordan August 13, 2018
News Daily News Starting Low and Going Lower: Some Benefit to Very Low LDL Levels Michael O'Riordan August 02, 2018
News Daily News New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI Michael O'Riordan July 31, 2018
News Daily News Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51 Michael O'Riordan July 06, 2018
News Daily News New Review Probes Possibility of CVD Prevention Without Aspirin Michael O'Riordan July 04, 2018
News Daily News Serial CTA Shines a Light on Statin Effects in Subclinical CAD Yael L. Maxwell June 15, 2018
News Daily News Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy Yael L. Maxwell June 08, 2018
News Daily News One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI Michael O'Riordan May 21, 2018
News Conference News SCAI 2018 Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI Todd Neale April 27, 2018
News Daily News FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen Michael O'Riordan April 25, 2018
News Daily News Less Bleeding, Similar Outcomes With Dual vs Triple Therapy After PCI in Patients With A-fib Todd Neale April 24, 2018
News Daily News FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled Michael O'Riordan April 24, 2018
News Daily News Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes Shelley Wood April 18, 2018
News Conference News ACC 2018 High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab Michael O'Riordan March 20, 2018
News Conference News ACC 2018 PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats Yael L. Maxwell March 14, 2018
News Conference News ACC 2018 Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial Yael L. Maxwell March 12, 2018
News Conference News ACC 2018 ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More Shelley Wood March 12, 2018